ANAPLASTIC THYROID CANCER
Clinical trials for ANAPLASTIC THYROID CANCER explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC THYROID CANCER trials appear
Sign up with your email to follow new studies for ANAPLASTIC THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to shrink deadly thyroid tumors before surgery
Disease control Recruiting nowThis early-phase study tests whether giving two drugs (XL092 and cemiplimab) before surgery can safely help remove anaplastic thyroid cancer completely in people with a specific gene type (BRAF V600E wildtype). About 12 adults with this rare, aggressive cancer will receive the dr…
Matched conditions: ANAPLASTIC THYROID CANCER
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 11:30 UTC
-
New hope for deadly thyroid cancer: drug combo shows promise in early trial
Disease control Recruiting nowThis study tests two drugs, pembrolizumab and lenvatinib, in people with a rare and fast-growing thyroid cancer called anaplastic thyroid cancer. The goal is to see if the combination can shrink tumors or slow the cancer's growth. About 20 adults who have not had prior treatment …
Matched conditions: ANAPLASTIC THYROID CANCER
Phase: PHASE2 • Sponsor: Saint Petersburg State University, Russia • Aim: Disease control
Last updated May 20, 2026 11:55 UTC